[Genetics of ischemic stroke: where are we now?].

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Orvosi Hetilap

• Publication date

  2011-03-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1556/OH.2011.29069PMID 21388942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study.

  2009cited by this paper
• Genomewide association studies of stroke.

  2009cited by this paper
• Ischaemic Stroke Subtypes and Their Genetic Basis: A Comprehensive Meta-Analysis of Small and Large Vessel Stroke

  2008cited by this paper
• Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke

  2008cited by this paper
• Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke.

  2008cited by this paper
• Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke

  2008cited by this paper
• Human Genetic Variation

  2007cited by this paper
• The combination of homozygous MTHFR 677T and angiotensin II type-1 receptor 1166C variants confers the risk of small-vessel-associated ischemic stroke

  2007cited by this paper
• Breakthrough of the year. Human genetic variation.

  2007cited by this paper
• APOA5 variants and metabolic syndrome in Caucasianss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three tables, one figure. Published, JLR Papers in Press, September 3, 2007.

  2007cited by this paper
• Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.

  2007cited by this paper
• Prediction of genetic risk for metabolic syndrome.

  2007cited by this paper
• A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release.

  2007cited by this paper
• The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.

  2007cited by this paper
• Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis.

  2006cited by this paper
• Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Studys⃞

  2006cited by this paper
• Determination of the Functionality of Common APOA5 Polymorphisms*

  2005cited by this paper
• Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke

  2005cited by this paper
• Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants

  2005cited by this paper
• Carotid Intima-Media Thickness, Plaques, and Framingham Risk Score as Independent Determinants of Stroke Risk

  2005cited by this paper
• Give me A5 for lipoprotein hydrolysis!

  2005cited by this paper
• Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

  2004cited by this paper
• Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.

  2004cited by this paper
• Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis

  2004cited by this paper
• Gene polymorphisms of the renin–angiotensin–aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant

  2004cited by this paper
• Framingham Stroke Risk Profile and Lowered Cognitive Performance

  2004cited by this paper
• Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke

  2003cited by this paper
• Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology.

  2003cited by this paper
• Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.

  2003cited by this paper
• Structure and Interfacial Properties of Human Apolipoprotein A-V*

  2003cited by this paper
• Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

  2002cited by this paper
• Genetics and ischaemic stroke.

  2000cited by this paper
• Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme.

  1998cited by this paper
• Hypertriglyceridemia as a cardiovascular risk factor.

  1998cited by this paper
• Recent developments in the molecular genetics of mitochondrial disorders.

  1998cited by this paper
• Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis

  1997cited by this paper
• Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease.

  1997cited by this paper
• The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease.

  1997cited by this paper
• Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.

  1997cited by this paper
• Modeling of risk factors for ischemic stroke. The Willis Lecture.

  1997cited by this paper
• The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with cerebral ischemia.

  1997cited by this paper
• A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

  1996cited by this paper
• A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene

  1996cited by this paper
• Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma.

  1995cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992cited by this paper
• Classification and natural history of clinically identifiable subtypes of cerebral infarction.

  1991cited by this paper
• A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals.

  1991cited by this paper
• Plasma lipoproteins and apolipoproteins.

  1974cited by this paper
• WHO on stroke.

  1972cited by this paper

• Association of AHSG Gene Polymorphisms with Ischemic Stroke in a Han Chinese Population

  2013cites this paper